India · Delayed Price · Currency is INR Vineet Laboratories Company Description
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India.
The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates.
It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde.
The company was incorporated in 2016 and is based in Hyderabad, India.
| Country | India |
| Founded | 2016 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 57 |
| CEO | Gaddam Ramana |
Contact Details
Address: 5-5-160, Malleswari Nilayam Hyderabad, 500074 India | |
| Phone | 91 40 2412 8833 |
| Website | vineetlabs.co.in |
Stock Details
| Ticker Symbol | 543298 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Gaddam Ramana | Chief Executive Officer |
| Satyanarayana Bhupathiraju | Chief Financial Officer |